MeSH D010373 - lice infestations
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ivermectin | Ivermectin |  | 2019-09-13 |  |  |
| Padagis | Ivermectin | Ivermectin |  | 2020-04-13 |  |  |
| Permethrin | Permethrin |  | 2003-04-21 |  |  | |
| Taro Pharmaceutical | Ivermectin | Ivermectin |  | 2020-05-06 |  |  |
| Malathion | Ovide | 2026-08-14 | 1982-08-02 |  |  | |
| Mylan | Malathion | Malathion |  | 2009-03-06 |  |  |
| Perrigo | Permethrin | Permethrin |  | 2001-12-20 |  |  |
| GSK | Permethrin | Nix |  | 1986-03-31 |  |  |
| Merck & Co | Ivermectin | Stromectol |  | 1996-11-22 |  |  |
| Bayer | Piperonyl butoxide, Pyrethrins | Rid Mousse |  | 2000-03-07 |  |  |
| Aurobindo Pharma | Permethrin | Elimite |  | 1989-08-25 |  |  |
| Zydus Therapeutics | Ivermectin | Ivermectin |  | 2022-08-02 |  |  |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
33%2/6
Phase 2
50%1/2
Phase 3
100%11/11
Approved: 7Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use